中药板块8月4日涨0.42%，陇神戎发领涨，主力资金净流出5.56亿元

Market Performance - The Traditional Chinese Medicine (TCM) sector rose by 0.42% on August 4, with Longshen Rongfa leading the gains [1] - The Shanghai Composite Index closed at 3583.31, up 0.66%, while the Shenzhen Component Index closed at 11041.56, up 0.46% [1] Top Gainers in TCM Sector - Longshen Rongfa (300534) closed at 12.09, up 7.18% with a trading volume of 646,800 shares and a turnover of 777 million yuan [1] - Weikang Pharmaceutical (300878) closed at 27.26, up 6.40% with a trading volume of 198,700 shares and a turnover of 513 million yuan [1] - Darentang (600329) closed at 41.20, up 6.30% with a trading volume of 164,600 shares and a turnover of 664 million yuan [1] Top Losers in TCM Sector - Biotech Valley (833266) closed at 12.80, down 8.51% with a trading volume of 215,700 shares and a turnover of 271 million yuan [2] - Datang Pharmaceutical (836433) closed at 8.19, down 4.88% with a trading volume of 204,800 shares and a turnover of 166 million yuan [2] - Huason Pharmaceutical (002907) closed at 20.00, down 3.57% with a trading volume of 390,300 shares and a turnover of 787 million yuan [2] Capital Flow Analysis - The TCM sector experienced a net outflow of 556 million yuan from institutional investors, while retail investors saw a net inflow of 375 million yuan [2] - The net inflow from speculative funds was 181 million yuan [2] Individual Stock Capital Flow - China Resources Sanjiu (000999) had a net inflow of 86.17 million yuan from institutional investors, while retail investors saw a net outflow of 56.84 million yuan [3] - Yabao Pharmaceutical (600351) had a net inflow of 57.28 million yuan from institutional investors, with retail investors experiencing a net outflow of 42.13 million yuan [3] - Tongrentang (600085) had a net inflow of 53.69 million yuan from institutional investors, while retail investors had a net outflow of 58.73 million yuan [3]